社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
老油条的原则
IP属地：广东
+关注
帖子 · 172
帖子 · 172
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
老油条的原则
老油条的原则
·
08-18
$正力新能(03677)$
正力现在是需要更多的资金流入进来，这样才会把股价修正，目前还是处于被严重低估阶段
看
248
回复
评论
点赞
1
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
08-18
$同源康医药-B(02410)$
同源康医药公布2026年中期业绩，研发成本为9494.3万元，同比增长7%;行政开支6255.4万元，同比增长61.3%;母公司拥有人应占亏损2489.7万元，同比收窄77.81%
看
199
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
08-18
$海致科技集团(02706)$
从公司基本面看，2025年Atlas智能体业务收入同比增长68.4%，成为第二增长曲线
看
185
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-30
$同源康医药-B(02410)$
同源康上方有压力，这是不可避免的，但是引入齐鲁制药后，也有很多的资金流入进来
看
711
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-30
$海致科技集团(02706)$
今天港股形势还可以，海致什么时候来个触底大反弹呢
看
419
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-21
$凯乐士科技(02729)$
根据弗若斯特沙利文数据，按2024年的收入计算，凯乐士科技位列中国前五大综合智能场内物流机器人公司
看
578
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-21
$同源康医药-B(02410)$
同源康目前涨幅还不错，有机会进一步升起来，争取早点破10块
看
626
回复
评论
点赞
1
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-21
$海致科技集团(02706)$
海致并非单纯项目型软件服务商，而是以图谱底座承接企业数据资产，以智能体产品切入业务流程执行，构建“数据治理-知识建模-图谱推理-智能体执行”的全栈能力
看
784
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-13
$凯乐士科技(02729)$
凯乐士目前还是围绕30这里进行反复的试探，但是大方向应该是要往上升起来
看
387
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-13
$同源康医药-B(02410)$
甲磺酸艾多替尼片是同源康医药自主研发的高选择性、新一代不可逆EGFR-TKI，在前期早期临床研究中已展现出优异的颅内病灶抑制能力与安全耐受性，为肺癌脑转移患者治疗带来全新突破可能
看
632
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"156361281180936","uuid":"156361281180936","gmtCreate":1607589937531,"gmtModify":1646408619245,"name":"老油条的原则","pinyin":"lytdyzlaoyoutiaodeyuanze","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":10,"tweetSize":172,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.06.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":2,"currentWearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":1},"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":598021603038528,"gmtCreate":1787019590630,"gmtModify":1787019592583,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/03677\">$正力新能(03677)$ </a> 正力现在是需要更多的资金流入进来，这样才会把股价修正，目前还是处于被严重低估阶段","listText":"<a href=\"https://laohu8.com/S/03677\">$正力新能(03677)$ </a> 正力现在是需要更多的资金流入进来，这样才会把股价修正，目前还是处于被严重低估阶段","text":"$正力新能(03677)$ 正力现在是需要更多的资金流入进来，这样才会把股价修正，目前还是处于被严重低估阶段","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/598021603038528","isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":598021697139712,"gmtCreate":1787019554424,"gmtModify":1787019556654,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康医药公布2026年中期业绩，研发成本为9494.3万元，同比增长7%;行政开支6255.4万元，同比增长61.3%;母公司拥有人应占亏损2489.7万元，同比收窄77.81%","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康医药公布2026年中期业绩，研发成本为9494.3万元，同比增长7%;行政开支6255.4万元，同比增长61.3%;母公司拥有人应占亏损2489.7万元，同比收窄77.81%","text":"$同源康医药-B(02410)$ 同源康医药公布2026年中期业绩，研发成本为9494.3万元，同比增长7%;行政开支6255.4万元，同比增长61.3%;母公司拥有人应占亏损2489.7万元，同比收窄77.81%","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/598021697139712","isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":598021342016776,"gmtCreate":1787019526802,"gmtModify":1787019528974,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 从公司基本面看，2025年Atlas智能体业务收入同比增长68.4%，成为第二增长曲线","listText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 从公司基本面看，2025年Atlas智能体业务收入同比增长68.4%，成为第二增长曲线","text":"$海致科技集团(02706)$ 从公司基本面看，2025年Atlas智能体业务收入同比增长68.4%，成为第二增长曲线","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/598021342016776","isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":591507265347888,"gmtCreate":1785379345053,"gmtModify":1785379347290,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康上方有压力，这是不可避免的，但是引入齐鲁制药后，也有很多的资金流入进来","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康上方有压力，这是不可避免的，但是引入齐鲁制药后，也有很多的资金流入进来","text":"$同源康医药-B(02410)$ 同源康上方有压力，这是不可避免的，但是引入齐鲁制药后，也有很多的资金流入进来","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/591507265347888","isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":591371377570768,"gmtCreate":1785379312761,"gmtModify":1785379314894,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 今天港股形势还可以，海致什么时候来个触底大反弹呢","listText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 今天港股形势还可以，海致什么时候来个触底大反弹呢","text":"$海致科技集团(02706)$ 今天港股形势还可以，海致什么时候来个触底大反弹呢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/591371377570768","isVote":1,"tweetType":1,"viewCount":419,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":588071343445112,"gmtCreate":1784603546050,"gmtModify":1784603548030,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02729\">$凯乐士科技(02729)$ </a> 根据弗若斯特沙利文数据，按2024年的收入计算，凯乐士科技位列中国前五大综合智能场内物流机器人公司","listText":"<a href=\"https://laohu8.com/S/02729\">$凯乐士科技(02729)$ </a> 根据弗若斯特沙利文数据，按2024年的收入计算，凯乐士科技位列中国前五大综合智能场内物流机器人公司","text":"$凯乐士科技(02729)$ 根据弗若斯特沙利文数据，按2024年的收入计算，凯乐士科技位列中国前五大综合智能场内物流机器人公司","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/588071343445112","isVote":1,"tweetType":1,"viewCount":578,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":588069977735200,"gmtCreate":1784603285224,"gmtModify":1784603287292,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康目前涨幅还不错，有机会进一步升起来，争取早点破10块","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康目前涨幅还不错，有机会进一步升起来，争取早点破10块","text":"$同源康医药-B(02410)$ 同源康目前涨幅还不错，有机会进一步升起来，争取早点破10块","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/588069977735200","isVote":1,"tweetType":1,"viewCount":626,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":588070228066680,"gmtCreate":1784603262358,"gmtModify":1784603264769,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 海致并非单纯项目型软件服务商，而是以图谱底座承接企业数据资产，以智能体产品切入业务流程执行，构建“数据治理-知识建模-图谱推理-智能体执行”的全栈能力","listText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 海致并非单纯项目型软件服务商，而是以图谱底座承接企业数据资产，以智能体产品切入业务流程执行，构建“数据治理-知识建模-图谱推理-智能体执行”的全栈能力","text":"$海致科技集团(02706)$ 海致并非单纯项目型软件服务商，而是以图谱底座承接企业数据资产，以智能体产品切入业务流程执行，构建“数据治理-知识建模-图谱推理-智能体执行”的全栈能力","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/588070228066680","isVote":1,"tweetType":1,"viewCount":784,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":585235788546240,"gmtCreate":1783909930394,"gmtModify":1783909932425,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02729\">$凯乐士科技(02729)$ </a> 凯乐士目前还是围绕30这里进行反复的试探，但是大方向应该是要往上升起来","listText":"<a href=\"https://laohu8.com/S/02729\">$凯乐士科技(02729)$ </a> 凯乐士目前还是围绕30这里进行反复的试探，但是大方向应该是要往上升起来","text":"$凯乐士科技(02729)$ 凯乐士目前还是围绕30这里进行反复的试探，但是大方向应该是要往上升起来","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/585235788546240","isVote":1,"tweetType":1,"viewCount":387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":585229802026368,"gmtCreate":1783909876668,"gmtModify":1783909878793,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 甲磺酸艾多替尼片是同源康医药自主研发的高选择性、新一代不可逆EGFR-TKI，在前期早期临床研究中已展现出优异的颅内病灶抑制能力与安全耐受性，为肺癌脑转移患者治疗带来全新突破可能","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 甲磺酸艾多替尼片是同源康医药自主研发的高选择性、新一代不可逆EGFR-TKI，在前期早期临床研究中已展现出优异的颅内病灶抑制能力与安全耐受性，为肺癌脑转移患者治疗带来全新突破可能","text":"$同源康医药-B(02410)$ 甲磺酸艾多替尼片是同源康医药自主研发的高选择性、新一代不可逆EGFR-TKI，在前期早期临床研究中已展现出优异的颅内病灶抑制能力与安全耐受性，为肺癌脑转移患者治疗带来全新突破可能","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/585229802026368","isVote":1,"tweetType":1,"viewCount":632,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}